Related references
Note: Only part of the references are listed.Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats
Songping Han et al.
DIABETES (2008)
Discovery of dapagliflozin: A potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes
Wei Meng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation:: An in vitro-in vivo study
B. Feng et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
THE AUXILIARY TABLE FOR GFR ESTIMATION ACCORDING TO THE MDRD FORMULA
Milena Stollova et al.
JOURNAL OF RENAL CARE (2008)
Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level
Kenji Katsuno et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
TIMP-1 transgenic mice recover from diabetes induced by multiple low-dose streptozotocin
Hongwei Jiang et al.
DIABETES (2007)
Active sugar transport in health and disease
E. M. Wright et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Islet β cell failure in type 2 diabetes
Marc Prentki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Familial renal glucosuria:: SLC5A2 mutation analysis and evidence of salt-wasting
J Calado et al.
KIDNEY INTERNATIONAL (2006)
Sodium glucose co-transporter 2 (SGLT2) inhibitors as potential antidiabetic agents
AL Handlon
EXPERT OPINION ON THERAPEUTIC PATENTS (2005)
Long-term outcome of renal glucosuria type 0:: the original patient and his natural history
S Scholl-Bürgi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
A novel SGLT2 mutation in a patient with autosomal recessive renal glucosuria
J Francis et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Molecular analysis of the SGLT2 gene in patients with renal glucosuria
R Santer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat
RJ McCrimmon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Share Paper
